Montreal-based Opalia has sold its first batch of cell-based whole milk to Hoogwegt, a Dutch dairy ingredients company and investor. This purchase marks a significant milestone, being the first instance of whole milk derived from bovine mammary cells globally. Hoogwegt intends to utilize the product for testing and developing fresh cheese, yogurt, and butter, with a prototype available at the Fi Europe conference in Frankfurt from November 17 to 19.
The partnership between Opalia and Hoogwegt began in 2024 with a CAD $2 million funding round and further solidified through a commercial agreement covering production in 2026 and 2027. Opalia plans to scale its technology to produce an output equivalent to one cow—approximately 28 litres daily—using a newly developed bioreactor. The company aims to acquire regulatory approvals in North America within a year, with food grade status targeted for 2028. At Fi Europe, both companies will seek potential partners for offtake agreements to further commercialize their innovative dairy products.
*This summary was generated using AI.
Read Full Article